Synthesis and evaluation of a new series of peptide-based endothelin receptor antagonists

Journal of Peptide Research

Volumn 65, Issue 4, 2005, Pages 440-444

  Dong, J ^a   Han, H ^a   Geng, B ^a   Li, X ^a   Gong, Z ^a   Liu, K ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Bioactivity; Endothelin receptor antagonist; Peptide; Synthesis

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR ANTAGONIST; ETP 060; ETP 061; ETP 062; ETP 063; ETP 064; ETP 065; ETP 066; ETP 067; ETP 068; ETP 069; ETP 088; ETP 101; ETP 503; ETP 504; ETP 505; ETP 506; ETP 507; ETP 508; ETP 509; ETP 510; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; TRIPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; EVALUATION; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; BLOOD PRESSURE; HYPERTENSION, PULMONARY; MOLECULAR STRUCTURE; OLIGOPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN;

EID: 16844367300     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2005.00230.x     Document Type: Article

References (11)

1. Sakurai, T., Yanagisawa, M. & Masaki, T. (1992) Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 13, 103-108.
2. Clozel, M., (2000) Endothelin receptor antagonists: current status and perspectives. J. Cardiovasc. Pharmacol. 35 (suppl. 2), S65-S68.
3. Wu, C., (2000) Recent discovery and development of endothelin recptor antagonists. Exp. Opin. Ther. Patents, 10, 1653-1658.
4. Wu, C.D., Decker, E.R., Holland, G.W., Brown, P.M., Stavros, F.D., Brock, T.A. & Dixon, R.A.F. (2001) Nonpeptide endothelin antagonists in clinical development. Drugs of Today 37, 442.
5. Barst, R.J., Ivy, D., Dingemanse J. et al. (2003) Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin. Pharmacol. Ther. 73, 372-382.
6. A antagonists: rational design and practical derivatization of N-terminal amino- and imino-carbonylated tripeptide derivatives. Bioorg. Med. Chem. Lett. 5, 1395-1400.
7. Fukami, T., Nagase, T., Fujita, T., Hayama, T., Niiyama, K., Mase, T., Nakajima, S., Fukuroda, T., Saeki, T., Nishikibe, M., Ihara, M., Yano, M. & Ishikawa, K. (1995) Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists. J. Med. Chem. 38, 4309-4324.
8. A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem. Biophys. Res. Comm. 195, 969-975.
9. Yu, W., Liang, Y., Liu, K., Zhao, Y., Fei, G. & Wang, H. (2002) The chemical syntheses and bioactivities of novel peptide-based endothelin antagonists. J. Pept. Res. 59, 134-138.
10. Potti, N. D. & Nobles, W. L. (1968) Improved method for preparing 3-azabicyclo [3.2.1] octane hydrochloride and synthesis of its phenothiazine derivatives. J. Pharm. Sci. 57, 1785-1787.
11. Yu, W., Liang Y., Liu, K. & Zhao, Y. (2002) Synthesis and resolution of phenylalanine analogues by halogen. Chem. J. Chinese Universities. 13, 1314-1317.